Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura

NCT00877838 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Migraine With Aura

Interventions

DRUG: NXN-188
DRUG: Placebo

Sponsor

Danish Headache Center

Collaborators

[object Object]